Celecoxib with or without zoledronic acid for hormone-naive prostate cancer: Survival results from STAMPEDE (NCT00268476).
James, N Sydes, M Clarke, Noel W Mason, M Dearnaley, D Spears, M Ritchie, A Russell, J Parker, C Rentsch, C
James, N
Sydes, M
Clarke, Noel W
Mason, M
Dearnaley, D
Spears, M
Ritchie, A
Russell, J
Parker, C
Rentsch, C
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2016
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Celecoxib with or without zoledronic acid for hormone-naive prostate cancer: Survival results from STAMPEDE (NCT00268476). 2016, 34(2):162-2 J Clin Oncol